Elutia Reports $8 Million Payment from Boston Scientific

MT newswire2026/10/01 21:41

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

05:41 PM EDT, 10/01/2026 (MT Newswires) -- Elutia (ELUT) said late Thursday it has received the full $8 million held in escrow from the sale of its BioEnvelope business to Boston Scientific (BSX). The payment came following an indemnity holdback period that began with the closing of the $88 million transaction in October last year, the company said. Elutia said it is now fully funded through the first year of the expected NXT-41x launch and into 2029. The company said it expects a "favorable" clearance decision from the US Food and Drug Administration for NXT-41x in the first half of 2027. Shares were up over 18% in after-hours trading.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

U.S. Treasury Secretary Janet Yellen defended the rise in U.S. Treasury yields, stating that this increase is a global phenomenon rather than unique to the United States, and does not warrant excessive concern. She partially attributed inflationary pressures to higher oil prices caused by the Iran conflict, and expects the energy shock to subside as hostilities ease. Yellen refuted the notion of an AI bubble, arguing that investments by major tech companies are grounded in solid business logic.

华尔街见闻•2026/10/04 03:06